Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet
- RxCUI
- 1734642
- RxNorm name
- Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet
- Display name
- Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet
- Full name
- Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZEPATIER | ELBASVIR AND GRAZOPREVIR | Merck Sharp & Dohme LLC | 164dc02a-9180-426a-b8b5-04ab39d2bbd4 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 1734642 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 164dc02a-9180-426a-b8b5-04ab39d2bbd4 | Zepatier (elbasvir 50 MG / grazoprevir 100 MG) Oral Tablet | SY | 22 | These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER ® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 2016 | 20260313 |
| 164dc02a-9180-426a-b8b5-04ab39d2bbd4 | elbasvir 50 MG / grazoprevir 100 MG Oral Tablet [Zepatier] | SBD | 22 | These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER ® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 2016 | 20260313 |
| 164dc02a-9180-426a-b8b5-04ab39d2bbd4 | Zepatier 50 MG / 100 MG Oral Tablet | PSN | 22 | These highlights do not include all the information needed to use ZEPATIER safely and effectively. See full prescribing information for ZEPATIER. ZEPATIER ® (elbasvir and grazoprevir) tablets, for oral use Initial U.S. Approval: 2016 | 20260313 |